This report identifies the vaccines market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the vaccines market.
This report segments the vaccines market on the basis of type, technology, disease indication, end user, and regional market as follows:Vaccines Market, By Type: Monovalent Vaccines, and Multivalent VaccinesVaccines Market, By Technology: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, and Recombinant VaccinesVaccines Market, By Disease Indication: Pneumococcal Disease, DTP, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Hepatitis, MMR, Varicella, and OthersThe report has focused study on vaccines market by basis of end user such as: Paediatrics, and AdultsThis report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the vaccines market.
Some of the major companies' profiles in detail are as follows:
Medimmune, LLC. (A Subsidiary of Astrazeneca)
Astellas Pharma Inc. Serum Institute of India
Emergent Biosolutions, Inc.
Merck & Co., Inc.
Download the full report: https://www.reportbuyer.com/product/4625493/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vaccines-market-by-type-monovalent-multivalent-by-technology-conjugate-vaccines-inactivated-and-subunit-vaccines-others-by-disease-indication-pneumococcal-disease-dtp-others-by-end-user-paediatrics-adults--regio-300400782.html